Sponsored by:

Nuclear Medicine: Page 374

Neoprobe inks new Lymphoseek deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe of Dublin, OH, has signed an agreement with the University of California, San Diego that will enable the company to expand its Lymphoseek radiopharmaceutical into applications in ultrasound and optical imaging.
April 20, 2005
Molecular Insight raises $28 million
By AuntMinnie.com staff writers
Radioisotope imaging developer Molecular Insight Pharmaceuticals of Cambridge, MA, said it has raised $28 million in Series C financing.
April 19, 2005
Philips installs first hybrid SPECT/CT units
By AuntMinnie.com staff writers
Multimodality vendor Philips Medical Systems of Andover, MA, has completed the first installations of its Precedence hybrid SPECT/CT systems.
April 18, 2005
Additional 510(k) for Medx computer
By AuntMinnie.com staff writers
Gamma camera refurbishing firm Medx has received an additional Food and Drug Administration 510(k) clearance for its NuQuest computer.
April 14, 2005
SNM offers $25,000 grant
By AuntMinnie.com staff writers
The Society of Nuclear Medicine is offering a new competitive grant to researchers in molecular imaging/nuclear medicine.
April 14, 2005
SNM bestows 2005 research grants
By AuntMinnie.com staff writers
The Society of Nuclear Medicine recently presented $65,000 in grants and awards for molecular imaging/nuclear medicine researchers and students.
April 13, 2005
International Isotopes, Alpha-Omega Services team up
By AuntMinnie.com staff writers
International Isotopes has signed a four-year cobalt source recycle agreement with brachytherapy sources and accessories developer Alpha-Omega Services of Bellflower, CA.
April 3, 2005
Siemens begins cash tender for CTI
By AuntMinnie.com staff writers
Siemens Medical Solutions has commenced its previously announced tender offer for all the outstanding shares of common stock of CTI Molecular Imaging.
March 31, 2005
FDG-PET's cost-effectiveness for soft-tissue sarcomas varies with lesion distance
By Jerry Ingram
FDG-PET appears to be more effective, accurate, and cost-effective than MRI for detecting high-grade and distant lesions in soft-tissue sarcomas. But the extra cost may not be warranted when it comes to detecting local lesions, according to researchers from Korea.
March 27, 2005
Complexities of normal pressure hydrocephalus bedevil neurological experts
Normal pressure hydrocephalus (NPH) is stirring up controversy. A condition often misdiagnosed as Alzheimer's disease, it causes gait disturbance, incontinence, and dementia. Among those who deal with the condition, disagreement simmers over what causes it, how to treat it, and even the way to diagnose it.
March 23, 2005
2005 03 24 09 57 28 706
Duke group delivers diagnostic CT and PET on PET/CT
By Jonathan S. Batchelor
ORLANDO, FL - Researchers from Duke University Medical Center in Durham, NC, have developed and implemented a set of protocols for obtaining diagnostic-quality PET and CT images in one session on a PET/CT scanner. They presented the results of their work at the Academy of Molecular Imaging (AMI) meeting on Wednesday.
March 23, 2005
FDG-PET/CT tops other technologies for lymphoma staging
By Jonathan S. Batchelor
ORLANDO, FL - Correctly staging and restaging lymphoma, both Hodgkin's and non-Hodgkin's, is crucial for patient management. Researchers from Stanford University Medical Center in Stanford, CA, evaluated patients with biopsy-proven lymphoma and found FDG-PET/CT to be superior to other modalities for staging, restaging, and anatomic localization.
March 22, 2005
Previous Page
Page 374 of 440
Next Page